The good usage of antibiotics in intensive therapy: Impact of a programme for rationalization of antimicrobial agents prescribing;DU BON USAGE DES ANTIBIOTIQUES EN REANIMATION: RESULTATS D'UN PROGRAMME DE RATIONALISATION DE LA PRESCRIPTION

Annales Francaises d'Anesthesie et de Reanimation

Volumn 17, Issue 1, 1998, Pages 27-31

  Mohammedi, I ^a   Duperret, S ^a   Vedrinne J M ^a   Allaouchiche, B ^a   Bui Xuan, B ^a   Bouletreau P ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Antibiotic; Bacterial resistance; Cost containment

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFAMANDOLE; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; GENTAMICIN; GLYCOPEPTIDE; IMIPENEM; METICILLIN; NETILMICIN; OFLOXACIN; OXACILLIN; PEFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; TICARCILLIN; TOBRAMYCIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; CATHETER INFECTION; CLINICAL TRIAL; ESCHERICHIA COLI; HUMAN; INFECTION; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; KLEBSIELLA PNEUMONIAE; LUNG DISEASE; MAJOR CLINICAL STUDY; MORTALITY; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRESCRIPTION; PSEUDOMONAS AERUGINOSA; RESUSCITATION; SINUSITIS; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTION;

EID: 0031915401     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(97)80178-5     Document Type: Article

References (23)

1. 1 Régnier B. Les services de réanimation sont les épicentres des épidémies hospitalières de bactéries multirésistantes aux antibiotiques. Réan Urg 1993 ; 2 : 363-5
2. 2 Archibald L, Phillips L, Monnet D, McGowan JE, Tenover F, Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997 ; 24 : 211-5
3. 3 Goldman DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 1996 ; 273 : 234-40
4. 4 Conférence de consensus sur l'antibioprophylaxie chirurgicale. Ann Fr Anesth Réanim 1994 ; 13 (Suppl) : S1-9
5. 5 Régnier B. Les bactéries multirésistantes aux antibiotiques en réanimation : contexte épidémiologique et stratégies de maîtrise. Pathol Biol 1996 ; 44 : 113-23
6. 6 Neu HC. The crisis in antibiotic resistance. Science 1992 ; 257 : 1064-73
7. 7 Nava JM, Bella F, Garau J, Lite J, Morera MA, Marti C et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 1994 ; 19 : 884-90
8. 8 Courcol RJ, Pinkas M, Martin GR. A seven year survey of antibiotic susceptibility and it's relationship with usage. J Antimicrob Chemother 1989; 23 : 441-51
9. 9 Moss F, McNicol MW, Mc Swiggan DA, Miller DL. Survey of antibiotic prescribing in a district general hospital I. pattern of use. Lancet 1981 ; II : 349-52
10. 10 Dunagan WC, Woodward RS, Medoff G, Gray JL, Casabar E, Lawrenz C et at. Antibiotic misuse in two clinical situations: positive blood culture and administration of aminoglycosides. Rev Infect Dis 1991 ; 13 : 405-12
11. 11 Blumberg HM, Rimland D, Carrol DJ, Terry P, Wachsmuth IK. Rapid development of ciprofloxacin resistance in methicillin-susceptible and resistant Staphylococcus aureus. J Infect Dis 1991 ; 163 : 1279-85
12. 12 Shalit I, Haas H, Berger SA. Susceptibility of Pseudomonas aeruginosa to fluoroquinolones following 4 years of use in a tertiary care hospital. J Antimicrob Chemother 1992 : 30 : 149-52
13. 13 Morrisson AJ, Wenzel RP. Epidemiology of infections due to Pseudomonas aeruginosa. Rev Infect Dis 1984 ; 6 : 627-42
14. 14 Veron M, Descamps P, Daoulas F, Loulergue J, Weber M, Mallet MN et al. Étude multicentrique de la sensibilité de Pseudomonas aeruginosa à six bêtalactamines. Med Mal Infect 1987 ; 17 : 401-11
15. 15 Bert F, Bruneau B, Lambert-Zechowsky N, Branger C. Étude épidémiologique de la sensibilité aux antibiotiques de Pseudomonas aeruginosa. Pathol Biol 1994 ; 42 : 491-7
16. 16 Voss A, Milatovic D, Wallrauch-Schwarz C, Rosdhal VT, Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994 ; 13 : 50-5
17. 17 McGowan JE, Finland M. Infection and antibiotic usage at Boston city Hospital: changes in prevalence during the decade 1964-1973. J Infect Dis 1974 ; 129 : 421-8
18. 18 Williams RR, Gross PA, Levine JF. Cost containment of the second-generation cephalosporines by prospective monitoring at a community teaching hospital. Arch Intern Med 1985 ; 145 : 1978-81
19. 19 Woodward RS, Medoff G, Smith MS, Gray JL. Antibiotic cost savings from formulary restrictions and physicians monitoring in a medical-school-affiliated hospital. Am J Med 1987 ; 83 : 817-23
20. 20 Himmelberg CJ, Pleasants RA, Weber DJ, Kessler JM, Samsa GP, Spivey JM et al. Use of antimicrobial drugs in adult before and after removal of a restriction policy. Am J Hosp Pharm 1991 ; 48 : 1220-7
21. 21 Harvey K, Stewart R, Hemming M, Moulds R. Use of antibiotic agents in a large teaching hospital. The impact of antibiotic guidelines. Med J Austr 1983 ; 2 : 217-21
22. 22 Evans RS, Classen DC, Pestotnik SL, Lunsgaarde HP, Burke JP. Improving empiric antibiotic selection using computer decision support. Arch Intern Med 1994 ; 154 : 878-84
23. 23 Murray MD, Kohler RB, McCartney MC, Main JW. Attitudes of house physicians concerning various antibiotic-use control programs. Am J Hosp Pharm 1988 ; 45 : 584-8